HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Enprofylline

HCID 1676
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
41078-02-8
Standard SMILES
CCCn1c(=O)[nH]c(=O)c2[nH]cnc21
InChIKey
SIQPXVQCUCHWDI-UHFFFAOYSA-N
Molecular formula
C8H10N4O2
Average molar mass
194.19 g/mol
Monoisotopic mass
194.08037556

Overview

Enprofylline is xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. It has a role as a non-steroidal anti-inflammatory drug, a bronchodilator agent, an anti-arrhythmia drug and an anti-asthmatic drug.

Names & identifiers

Preferred name
Enprofylline
IUPAC
3-propyl-7H-purine-2,6-dione
English name
ENPROFYLLINE
Molecular formula
C8H10N4O2
Molecular weight
194.19

Names & synonyms

ENPROFYLLINE41078-02-83-Propylxanthine3-n-PropylxanthineEnprofilinaEnprofyllinum3,7-Dihydro-3-propyl-1H-purine-2,6-dione1H-Purine-2,6-dione, 3,7-dihydro-3-propyl-D-4028DTXSID90451863-Propyl-3,7-dihydro-purine-2,6-dioneDT7DT5E518
Show more names
nilyphENPROPHYLLINEEnprofyllilie3-Propylxanthfine
3-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dioneD 4028DTXCID7025186CHEBI:126237RefChem:590853255-201-83-propyl-7H-purine-2,6-dioneEnprofilina [INN-Spanish]

Database identifiers

CAS
41078-02-8
PubChem CID
1676
DTXSID
DTXSID9045186
ChEMBL
CHEMBL279898
ChEBI
CHEBI:126237
UNII
DT7DT5E518
EC Number
255-201-8
Nikkaji
J16.542E

Properties

Computed structural properties

XLogP
0.3
Topological polar surface area
78.1 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
2
Heavy atoms
14
Formal charge
0
Complexity
268

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2 items

-0.2

0.33

Solubility · 2 items

5.68e+00 g/L

>29.1 [ug/mL] (The mean of the results at pH 7.4)

Melting Point · 2 items

287-289 °C

287 - 289 °C

Physical DescriptionSolid

Physicochemical properties

Melting point
287 · 287-289 °C
Density
1.38 g/cm3 · 1.38 g/cm3
storage temp.
2 · 2-8°C
solubility
DMSO: soluble
form
solid
pka
10.26 · 10.26±0.20(Predicted)
color
white

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

wgk
3
rtecs
UO8439700
risk_code
20/21/22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
36
Hazard statements
H332-H302-H312
Precautionary statements
P280-P302+P352-P312-P322-P363-P501-P261-P271-P304+P340-P312-P264-P270-P301+P312-P330-P501

Chemistry & industry

Pharmacology

Protein Binding49%
PharmacodynamicsEnprofylline is a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine. It antagonizes erythrocyte phosphodiesterase, increasing cAMP activity.
Mechanism of Action · 1 item

Enprofylline inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, enprofylline also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.

Biological Half-Life1.9 hours
MeSH Pharmacological Classification · 3 items

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Drugs that are used to treat asthma.

Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.

Absorption, Distribution and ExcretionRapidly absorbed from the digestive tract
Cellular LocationsCytoplasm
Applications · 3 items

Description3-Propylxanthine is a xanthine derivative that antagonizes adenosine receptors (Kis = 44, 32, and 6.3 μM for A1, A2A, and A2B, respectively) and cAMP phosphodiesterase (Ki = 42 μM). Through these actions, 3-propylxanthine induces smooth muscle relaxation, blocks smooth muscle contraction and VEGF secretion driven by adenosine receptor agonists, and reduces bronchial hyperresponsiveness.

UsesBronchodilator.

Related reactions

9 records
New reaction record
HRID 215047 reaction equation
HRID 215047As reactant
HRID 323855 reaction equation
HRID 323855As reactant
HRID 620144 reaction equation
HRID 620144As reactant
HRID 671670 reaction equation
HRID 671670As reactant
HRID 960497 reaction equation
HRID 960497As reactant
HRID 985943 reaction equation
HRID 985943As reactant
HRID 1943793 reaction equation
HRID 1943793As reactant
HRID 2234924 reaction equation
HRID 2234924As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CAS DataBase Reference
41078 · 41078-02-8
FDA UNII
7 DT5E518 · DT7DT5E518
Comptox DTXSID
9045186 · DTXSID9045186
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
332 · H332-H302-H312
Precautionary statements
280 · P280-P302+P352-P312-P322-P363-P501-P261-P271-P304+P340-P312-P264-P270-P301+P312-P330-P501
Hazard Codes
Xn
Risk Statements
20 · 20/21/22
Safety Statements
36 · 36
WGK Germany
3 · 3
RTECS
8439700 · UO8439700

UsesEnprofylline is a xanthine lacking adenosine receptor antagonism.

Upstream & downstream products

Upstream raw materials

Cyanoacetic acid
Additional notes · 1 item

DefinitionChEBI: Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic n uropathy.